Review
Innovative somatic treatments for depression
Affiliations
- PMID: 2017569
Item in Clipboard
Review
Innovative somatic treatments for depression
Psychiatr Med.
1991.
Abstract
This chapter will briefly review the current theories on the biochemical etiology of depression that are contributing toward the development of innovative somatic treatments. A description of clinically approved pharmacological treatments will be described in detail. Investigational pharmacological treatments that have demonstrated a high probability for general clinical use will also be discussed. Finally, a description of sleep deprivation will be included.
Similar articles
-
Antidepressant combination and potentiation.Psychiatr Med. 1991;9(1):55-75. Psychiatr Med. 1991. PMID: 2017568 Review.
-
Drug treatment of depression in general practice.Practitioner. 1982 Feb;226(1364):316-20. Practitioner. 1982. PMID: 7088828 No abstract available.
-
Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies.Synapse. 1992 Feb;10(2):141-68. doi: 10.1002/syn.890100209. Synapse. 1992. PMID: 1585257 Review.
-
Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.Pharmacopsychiatry. 2008 Nov;41(6):252-7. doi: 10.1055/s-0028-1083819. Epub 2008 Dec 9. Pharmacopsychiatry. 2008. PMID: 19067263
-
Pharmacotherapy of dysthymia: a review.J Clin Psychopharmacol. 1991 Apr;11(2):83-92. J Clin Psychopharmacol. 1991. PMID: 2056146 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical